In 2023, the import value of insulin in dosage forms to India was recorded at approximately 231 million USD. The forecast for 2024 indicates a 3.2% increase to 238.31 million USD, followed by a consistent year-on-year growth trend: a 3.0% rise in 2025, a 2.9% increase in 2026, 2.7% in 2027, and a 2.6% increment in 2028, reaching 266.27 million USD. The 5-year compound annual growth rate (CAGR) from 2024 to 2028 is projected to be around 2.89%.

Future trends to watch for include:

An aging population increasing demand for insulin, potentially driving higher import values.
Technological advancements in insulin delivery and formulation, impacting pricing and demand.
Government policies affecting import tariffs and healthcare spending could alter market dynamics.